Results

Total Results: over 10,000 records

Showing results for "cancer".
Users also searched for: colon cancer screening

321. Clinical Classifications for Health Policy Research: Hospital Inpatient Statistics, 1995
     hcup-us.ahrq.gov/reports/natstats/his95/appaa.htm
     September 01, 1998 - 20260 20261 20262 20263 20264 20265 20266 20267 20268 2340 2348 2349 7951 42 Secondary malignancies … 1975 1976 1977 1978 1980 1981 1982 1983 1984 1985 1986 1987 19881 19882 19889 43 Malignant … neoplasm without specification of site 1990 1991 44 Neoplasms of unspecified nature or uncertain … 2399 45 Maintenance chemotherapy, radiotherapy V580 V581 V661 V662 V671 V672 46 Benign … benign neoplasm V1272 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111

322. Bladder-Cancer-Non-Muscle-Invasive Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
     October 01, 2015 - These include the stage of the cancer, tumor grade (higher grade tumors are more likely to recur and … progress), whether the tumor is an initial tumor or a recurrence, number and size of tumors, and patient … tumors (SOE: high) … versus smaller tumors (SOE: low) … 1 cm or >2 cm) vs. smaller tumors.

323. Bladder-Cancer-Non-Muscle-Invasive Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
     October 01, 2015 - These include the stage of the cancer, tumor grade (higher grade tumors are more likely to recur and … progress), whether the tumor is an initial tumor or a recurrence, number and size of tumors, and patient … tumors (SOE: high) … versus smaller tumors (SOE: low) … 1 cm or >2 cm) vs. smaller tumors.

324. Summary of USPSTF Final Recommendation: Screening for Breast Cancer (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Qs4k3tBM8wdzudSpKro7-U
     April 01, 2024 - as a family history of breast cancer (ie, a first- degree relative with breast cancer) or having dense … diagnosed with triple-negative cancers (ie, ER-, PR-, and HER2-), which are more aggressive tumors … Breast cancer is the second most common cancer and the second most common cause of cancer death among … In 2023, an estimated 43,170 women died of breast cancer. … • The National Cancer Institute has information on breast cancer screening for health care professionals

325. Imaging Techniques for the Surveillance, Diagnosis, and Staging of Hepatocellular Carcinoma | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/liver-cancer/research-protocol/

326. Archived: Final Evidence Summary: Vitamin Supplementation to Prevent Cancer and CVD: Counseling and Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary53/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-and-preventive-medication-2003
     July 01, 2003 - Colonic Polyps Studies of the efficacy of vitamin combinations to prevent colonic neoplasia had … intraephithelial neoplasia; SU.VI.MAX, Supplementation en VItamines et Mineraux Antioxydants; SECURE … Alpha-Tocopherol Beta-Carotene (ATBC) Study Group, 1994 9 13,602 13,669 Prior MI, severe angina, proven malignancy … Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms … Chemoprevention of colorectal tumors: role of lactulose and of other agents.

327. Topic Brief: Accelerated Partial Breast Irradiation for Breast Cancer (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-apbi-breast-cancer.pdf
     August 01, 2022 - patients with early stage breast cancer reduces tumor recurrence and increases survival.4 According … cancer stage, tumor size, tumor margin status, estrogen receptor status, etc. … Comparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service. … syndrome"/ or inflammatory breast neoplasms/ or triple negative breast neoplasms/ or unilateral breast … neoplasms/ (295124) 2 (breast adj5 (cancer* or carcinoma* or invasive or malignan* or noninvasive or

328. Topic Brief: Accelerated Partial Breast Irradiation for Breast Cancer (pdf file)
     effectivehealthcare-admin.ahrq.gov/system/files/docs/topic-brief-apbi-breast-cancer.pdf
     August 01, 2022 - patients with early stage breast cancer reduces tumor recurrence and increases survival.4 According … cancer stage, tumor size, tumor margin status, estrogen receptor status, etc. … Comparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service. … syndrome"/ or inflammatory breast neoplasms/ or triple negative breast neoplasms/ or unilateral breast … neoplasms/ (295124) 2 (breast adj5 (cancer* or carcinoma* or invasive or malignan* or noninvasive or

329. Disposition of Comments for Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: An Update of a 2008 Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
     December 16, 2014 - PIVOT conducted in the US and primarily involved men with PSA detected tumors. … Nearly 80% of SPCG-4 subjects had T2 (palpable) tumors vs. only about 45% in PIVOT. P 59. … The report focuses only on T1 through T3a cancers. … , Reduces the risk of a second malignant neoplasms (SMN) in prostate patients compared with contemporary … Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x- ray therapy for

330. Disposition of Comments for Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: An Update of a 2008 Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
     December 16, 2014 - PIVOT conducted in the US and primarily involved men with PSA detected tumors. … Nearly 80% of SPCG-4 subjects had T2 (palpable) tumors vs. only about 45% in PIVOT. P 59. … The report focuses only on T1 through T3a cancers. … , Reduces the risk of a second malignant neoplasms (SMN) in prostate patients compared with contemporary … Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x- ray therapy for

331. Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/breast-cancer-imaging/research-protocol
     December 17, 2013 - stage Comparator Comparison of multiple imaging modalities No comparator None Outcomes Tumor … of Items Found 1 exp Diagnostic Imaging 1737346 2 exp Breast Neoplasms/dh, dt, pc, rt, su, … Diet Therapy, Drug Therapy, Prevention & Control, Radiotherapy, Surgery, Therapy] 101054 3 exp Neoplasm … survival analysis/ 190795 11 6 or 7 1163519 12 1 and 2 and 5 and 11 632 13 exp *Breast Neoplasms … Type(s) of imaging described Comparator Type(s) of comparators, if any Outcomes measured Tumor

332. Local Therapies for Unresectable Primary Hepatocellular Carcinoma: Comparative Effectiveness Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/liver-cancer-therapy/research-protocol
     March 20, 2012 - Unlike most solid tumors, the future incidence of and mortality rate due to HCC are projected to increase … using the following string of search terms: "Carcinoma, Hepatocellular"[Mesh] OR (hepatocellular AND (neoplasm … * OR cancer OR cancers OR carcinoma)) AND Unresectable OR nonresectable OR inoperable OR irresectable … comparative studies, and case series by using the following string of search terms: hepatocellular AND (neoplasm … * OR cancer OR cancers OR carcinoma) AND (unresectable OR nonresectable OR inoperable OR irresectable

333. Draft Recommendation: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/breast-cancer-screening-adults
     May 09, 2023 - (i.e., ER-, PR-, and HER2-), which are more aggressive tumors, compared with White women, 5 and are … detection or in tumor characteristics (tumor size, histologic grade, or node status) when comparing … The risk of a stage IIB or higher cancer diagnosis and of having a tumor with less favorable prognostic … Interval breast cancer rates and tumor characteristics in the prospective population-based Malmö breast … Research is needed to identify prognostic indicators for breast tumors (DCIS and potentially some early-stage

334. Archived: Evidence Summary: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer--brca-testing-ovarian-cancer-screeni
     September 15, 2005 - The development of interval breast malignancies in patients with BRCA mutations. … Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 … Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. … The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. … Working Party of Hereditary Tumors. ** Plans A, B, C, D: guidelines on genetic counseling referral for

335. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. | PSNet
     psnet.ahrq.gov/issue/effect-delays-2-week-wait-cancer-referral-pathway-during-covid-19-pandemic-cancer-survival-uk
     October 21, 2020 - Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival … referrals on cancer survival. … proportion of patients with early-stage tumors progressing from having curable to incurable disease. … Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival … cancer during the COVID-19 pandemic.

336. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/colorectal-cancer-screening_research-protocol.pdf
     May 18, 2011 - For advanced neoplasia. … Gastroenterology, American Society of Clinical Oncology, Digestive Disease Week, Gastrointestinal Cancers … Molecular detection of colorectal neoplasia. [Review] [107 refs]. … 2 f-dna.ti,ab. 3 sdna.ti,ab. 4 DNA/ 5 DNA Methylation/ 6 DNA Mutational Analysis/ 7 DNA, Neoplasm … Colonic Polyps/ 14 Colonic Neoplasms/ 15 Sigmoid Neoplasms/ 16 Rectal Neoplasms/ 17 Anus Neoplasms

337. Prostate-Cancer-Test Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_executive.pdf
     April 01, 2013 - leading cause of cancer deaths in men in the United States.1,2 Most patients have slow-growing tumors … lifetime risk of dying from the disease is only 3 percent.1,3,5 However, some patients have aggressive tumors … effectiveness of using PCA3 testing alone, or in combination with the standard prognostic workup (e.g., tumor … PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume. … PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates

338. Prostate-Cancer-Test Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_executive.pdf
     April 01, 2013 - leading cause of cancer deaths in men in the United States.1,2 Most patients have slow-growing tumors … lifetime risk of dying from the disease is only 3 percent.1,3,5 However, some patients have aggressive tumors … effectiveness of using PCA3 testing alone, or in combination with the standard prognostic workup (e.g., tumor … PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume. … PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates

339. Local Therapies for Unresectable Primary Hepatocellular Carcinoma: Comparative Effectiveness Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/liver-cancer-therapy/research-protocol
     December 01, 2019 - Unlike most solid tumors, the future incidence of and mortality rate due to HCC are projected to increase … using the following string of search terms: "Carcinoma, Hepatocellular"[Mesh] OR (hepatocellular AND (neoplasm … * OR cancer OR cancers OR carcinoma)) AND Unresectable OR nonresectable OR inoperable OR irresectable … comparative studies, and case series by using the following string of search terms: hepatocellular AND (neoplasm … * OR cancer OR cancers OR carcinoma) AND (unresectable OR nonresectable OR inoperable OR irresectable

340. NHQDR Web Site - National Cancer Trend Details
     nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Diseases_and_Conditions/Cancer
     Cancer Trend Bar Graphs National Cancer Quality Measures Trend Over Time Trending information is … (tumors diagnosed at regional or distant stage) per 100,000 population age 50 and over -2.9 Lung cancer … -2.4 Breast cancer deaths per 100,000 female population per year -1.7 Cervical cancer diagnosed … at advanced stage (all invasive tumors) per 100,000 women age 20 and over -1.1 Measures That Are … , distant stage, or local stage with tumor greater than 2 cm) per 100,000 women age 40 and over -0.6